| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000238260.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016935486 |
Resistant |
| ENSG00000238260.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.049401809 |
Sensitive |
| ENSG00000238260.1 |
Ponatinib |
Skin cutaneous melanoma |
0.005005182 |
Sensitive |
